CHICAGO, ILLINOIS--(Marketwire - November 05, 2007) - MonoGen, Inc. (TSX: MOG) (“Corporation”) announced today the addition of Jan L. Zorn to its executive management team. Ms. Zorn will join the company as Vice President of Regulatory and Clinical Affairs effective December 1, 2007. Jan has 34 years of experience with 25 of that specifically in the regulatory and clinical affairs area. Jan’s recent history includes 4 years in the position of Vice President of Regulatory, Clinical and Quality Assurance at Optobionics Corporation as well as 5 years in the position of Director of Regulatory and Clinical Affairs at Aksys Ltd. Prior to that she held various regulatory and clinical affairs positions at Caremark, Baxter, and Amersham. She has conducted many multi-center clinical trials, generated FDA submissions, and received approvals for a number of Class 2 and Class 3 products. Ms. Zorn earned her BS in Biology from St. Mary’s College in Notre Dame, Indiana.
